WDB coco Co (TSE:7079) Retained Earnings : 円2,720 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. WDB coco Co's retained earnings for the quarter that ended in Dec. 2023 was 円2,720 Mil.

WDB coco Co's quarterly retained earnings increased from Jun. 2023 (円2,308 Mil) to Sep. 2023 (円2,516 Mil) and increased from Sep. 2023 (円2,516 Mil) to Dec. 2023 (円2,720 Mil).

WDB coco Co's annual retained earnings increased from Mar. 2021 (円1,032 Mil) to Mar. 2022 (円1,597 Mil) and increased from Mar. 2022 (円1,597 Mil) to Mar. 2023 (円2,245 Mil).

WDB coco Co Retained Earnings Historical Data

The historical data trend for WDB coco Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WDB coco Co Retained Earnings Chart

WDB coco Co Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Retained Earnings

Get a 7-Day Free Trial

556.62

736.18

1,031.67

1,596.67

2,244.76

WDB coco Co Quarterly Data
	Mar18	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Retained Earnings	Get a 7-Day Free Trial															2,046.92	2,244.76	2,308.28	2,515.68	2,720.43

WDB coco Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

WDB coco Co (TSE:7079) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

WDB coco Co (TSE:7079) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127

Website

https://www.wdbcoco.com

WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co (TSE:7079) Headlines

No Headlines